# OnCo record nct07745361 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07745361/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07745361", "NCT07745361" ;
  schema:name "Study of Oral MRT-2359 With Apalutamide in Prostate Cancer"@en ;
  schema:alternateName "MODeFIRe-1"@en ;
  schema:description "A phase 2 trial of Apalutamide in prostate cancer, run by Monte Rosa Therapeutics, Inc, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07745361/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07745361> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2026-08" ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:technologies <https://onco.cc/technologies/androgen-deprivation/> ;
  onco:drugs <https://onco.cc/drugs/apalutamide/> ;
  onco:companies <https://onco.cc/companies/monte-rosa/> .